SPIKEVAX
SPIKEVAX
Approved
DIN Number
02541270
Drug Class
Human
Market Date
Sep 18, 2023
Company
HC
moderna biopharma canada corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02541270
AIG Number0166225001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormDispersion
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
*SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYAActive
Strength: 0.1 MG / ML
Monograph: *SARSCOV2 S-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA